The biologics landscape is advancing at breakneck speed, with novel antibody formats, immunotherapies, and biosimilars redefining patient care. Yet, the R&D process remains hindered by the complexity of biological data. From high-throughput screening and flow cytometry to protein engineering and manufacturing, valuable data is often trapped in spreadsheets, siloed legacy systems, or unconnected lab instruments.

At Elucidata, we help biopharma companies break free from these data bottlenecks. Our platform, Polly, and our specialized Biologics Data Management solutions provide a unified foundation for your entire biologics lifecycle. We automate the ingestion and harmonization of complex multi-modal data by linking sequences to assay results and production parameters to create a single source of truth.

Whether you are optimizing antibody discovery workflows, integrating platforms like Genedata Biologics, or preparing data for predictive AI modeling, we turn your "messy" biological data into an asset that accelerates candidate selection and reduces manual effort.

Meet our team at the Festival of Biologics USA to learn how we are helping top biopharmaceuticals  cut manual data processing time by 95% and bring life-saving biologics to market faster.

‍